Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

2012, the Year of the Hedge Fund

Despite poor returns last year, 2012 is poised to be the year of the hedge fund. “Investors may add about $80 billion of new capital to hedge funds globally this year, the most since 2007,” Businessweek reports.

Hedge funds, on average, lost just over 4% in 2011, making it the second-worse annual performance on record, but investors appear confident. “About 56 percent of investors surveyed by Barclays plan to increase such investments in the coming year, more than seven times the number that plan to reduce their allocations,” writes Businessweek. “Investors may also reallocate about $300 billion of existing investments to hedge funds within the same strategies or across strategies.”Barclays PLC (ADR) (NYSE:BCS)

The survey found that “global macro and systematic and volatility funds may be the biggest recipients of new capital as investors look to allocate money to short-term traders with lower correlation to stock markets.” Smaller hedge funds are also likely to see increases in investment. Investors are expected to invest increasingly more money into hedge funds with less than $1 billion in assets, continuing the trend seen last year when smaller funds “doubled their share of the net industry inflows to 18 percent last year over 2010.”

“Smaller managers are frequently seen by investors to be more agile in adapting their existing strategies to generate alpha,” says Louis Molinari, the head of capital solutions for Barclays’ prime services division. ‘With the greater transparency and better fee and liquidity terms that many new and smaller funds offer, investors continue to gain confidence with investing in this segment of the hedge fund industry.”

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!